Product image of Mometasone Furoate Sandoz Ltd (Mometasone Furoate) supplied by GNH India

Mometasone Furoate Sandoz Ltd

Active Ingredient:
Mometasone Furoate
Origin:
EU

Mometasone Furoate Sandoz Ltd (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Furoate Sandoz Ltd, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions such as psoriasis, eczema and allergic skin reactions in adults and children.

GNH India supplies Mometasone Furoate Sandoz Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Manufacturer / TM Owner

Sandoz Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate is a topical corticosteroid used to manage inflammatory skin disorders.

  • Psoriasis: reduces scaling, erythema and plaque thickness.
  • Eczema: alleviates itching, redness and swelling.
  • Atopic dermatitis: controls flare‑ups and improves skin barrier function.
  • Allergic skin reactions: diminishes inflammation and hives caused by allergens.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and interferes with transcription factors such as NF‑κB and AP‑1. This suppresses the production of pro‑inflammatory cytokines, chemokines and adhesion molecules, leading to reduced leukocyte infiltration and inhibition of the immune response in the skin.

Side Effects

Mometasone furoate may cause local and systemic adverse reactions when applied to the skin.

Common Side Effects

  • Burning or stinging sensation at the application site.
  • Pruritus or mild itching.
  • Dryness or peeling of the treated skin.
  • Erythema or mild redness.
  • Folliculitis or acneiform eruptions.
  • Telangiectasia with prolonged use.

Serious or Rare Side Effects

  • Skin atrophy or thinning.
  • Striae (stretch marks) formation.
  • Secondary bacterial, fungal or viral skin infections.
  • Hypersensitivity reactions such as contact dermatitis.
  • Systemic effects like adrenal suppression with extensive application.
  • Delayed wound healing or ulceration.

Precautions & Warnings

Before using Mometasone furoate, consider the following safety measures.

  • Application area: limit use to affected skin only and avoid large surface areas.
  • Duration of therapy: use for the shortest effective period to minimize skin atrophy.
  • Concomitant infections: do not apply on active bacterial, fungal or viral skin infections.
  • Age restrictions: avoid use on infants unless specifically prescribed.
  • Occlusive dressings: avoid covering treated skin with airtight dressings unless directed.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Mometasone furoate can interact with other agents that affect skin integrity or systemic corticosteroid levels. Major Interactions (Avoid):\n- Systemic corticosteroids: may increase risk of systemic side effects such as adrenal suppression.

  • Antifungal or antibacterial topicals: concurrent use may mask signs of infection.

Moderate Interactions (Monitor Closely)

  • Skin‑lightening agents (e.g., hydroquinone): may increase irritation.
  • Retinoids (topical or oral): may exacerbate skin thinning.
  • Immunosuppressants: monitor for heightened infection risk.

Frequently Asked Questions

Mometasone Furoate Sandoz Ltd is a topical corticosteroid indicated for the treatment of inflammatory skin disorders such as psoriasis, eczema, atopic dermatitis and allergic skin reactions. It helps to reduce redness, itching, swelling and scaling associated with these conditions.

Mometasone furoate binds to glucocorticoid receptors inside skin cells, forming a complex that moves to the nucleus and suppresses the activity of inflammatory transcription factors. This reduces the release of cytokines and other mediators, leading to decreased inflammation and immune response in the treated area.

The appropriate dose and frequency of Mometasone Furoate Sandoz Ltd are determined by the prescribing healthcare professional based on the specific condition, severity, patient age and treatment area. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for Mometasone Furoate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone furoate is a high‑potency topical corticosteroid, offering stronger anti‑inflammatory effects than low‑ to medium‑potency agents such as hydrocortisone. Compared with other high‑potency steroids like clobetasol, it provides similar efficacy with a slightly lower risk of systemic absorption when used as directed.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture, direct sunlight and extreme heat to maintain stability and potency.

Mometasone Furoate is applied topically to the affected skin area in a thin layer, usually once or twice daily as directed by a healthcare professional. The skin should be clean and dry before application, and hands should be washed after use.

Serious risks include skin atrophy, striae formation, secondary infections, and systemic effects such as adrenal suppression when large areas are treated for prolonged periods. Patients should report any signs of severe thinning, unusual bruising or systemic symptoms to their clinician promptly.

Mometasone Furoate should be avoided in individuals with known hypersensitivity to mometasone or any formulation components, in patients with untreated bacterial, fungal or viral skin infections, and in infants unless specifically prescribed by a qualified professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT